Compare
NovelStem International Corp. vs Regenerative Medical Technology Group Inc. vs RedCloud Holdings plc vs Inno Holdings Inc.
| Latest fiscal year | NovelStem International Corp. NSTMRevenue covers only part of its income (partial revenue) | Regenerative Medical Technology Group Inc. RMTG | RedCloud Holdings plc RCT | Inno Holdings Inc. INHD |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-09-30 |
| Revenue | n/a | $5.10M | $48.54M | $2.85M |
| Revenue growth (YoY) | n/a | +24.2% | +4.4% | +221.4% |
| Gross margin | n/a | 55.1% | n/a | 2.0% |
| Operating margin | n/a | -17.0% | -89.8% | -153.3% |
| Net margin | n/a | -153.2% | -95.3% | -248.7% |
| Net income | $2.38M | -$7.81M | -$46.24M | -$7.08M |
| EPS (Diluted) | $0.05 | -$0.62 | -$1.03 | -$1.31 |
| Operating cash flow | -$167.6K | -$706.5K | -$36.98M | -$4.73M |
| Free cash flow | n/a | -$1.31M | -$37.13M | n/a |
| Cash & equivalents | n/a | $956.7K | $479.0K | $10.13M |
| Total assets | $15.8K | $4.49M | $12.65M | $16.01M |
| Total liabilities | $2.16M | $39.23M | $19.62M | $838.7K |
| Shareholders' equity | -$2.14M | -$34.75M | -$6.96M | $15.17M |
| Return on year-end equity | n/a | n/a | n/a | -46.7% |
| Shares outstanding | 46.88M | 13.14M | 55.32M | 12.95M |
Revenue, most recent five fiscal years
| Fiscal year | NovelStem International Corp. | Regenerative Medical Technology Group Inc. | RedCloud Holdings plc | Inno Holdings Inc. |
|---|---|---|---|---|
| Latest | n/a | $5.10M Ended 2025-12-31 | $48.54M Ended 2025-12-31 | $2.85M Ended 2025-09-30 |
| 1 year earlier | n/a | $4.11M Ended 2024-12-31 | $46.50M Ended 2024-12-31 | $885.5K Ended 2024-09-30 |
| 2 years earlier | n/a | $2.41M Ended 2023-12-31 | $19.81M Ended 2023-12-31 | $799.7K Ended 2023-09-30 |
| 3 years earlier | n/a | $1.53M Ended 2022-12-31 | n/a | $4.50M Ended 2022-09-30 |
| 4 years earlier | n/a | $437.9K Ended 2021-12-31 | n/a | n/a |